COVID-19 and Janssen
Medicines Questions
While a lot has changed over the past few months, at Janssen, our unwavering commitment to you and your patients hasn’t, and never will.
The challenges brought on by COVID-19 have strengthened our commitment to ensuring you can always rely on us and our medicines. Our teams are working hard to maintain a consistent product supply, ensuring you have essential treatment information at your fingertips, and providing your patients the resources to access and afford their Janssen medicines.
You and your patients are, and always will be Janssen’s primary focus, and meeting your expectations for the highest quality medicines is what drives us every day.
As the pharmaceutical companies of Johnson & Johnson, Janssen has the unique ability to draw on our family of companies’ deep scientific expertise and extensive partnerships to take a leading role in the fight against COVID-19 on three fronts. We are expediting the development and manufacturing of a vaccine that could prevent COVID-19 in the future. We are working with global partners to support testing across our portfolio of medicines in both the lab and in clinical trials, to determine whether they can help treat the virus or ease associated complications that increase the severity of your patient’s case. And, as you would expect, we’re supporting our communities and health workers on the frontlines through monetary and supply contributions.
Whether fighting COVID-19, cancer, autoimmune disease, heart disease and diabetes, infectious diseases including HIV, pulmonary arterial hypertension, or mental illness, we never stop working to create a future where disease is a thing of the past.
Thank you for all you do every day for your patients and communities. We know that you depend on us. Know that we’re behind you.
Scott White
Company Group Chairman
North America Pharmaceuticals
Johnson & Johnson
JANSSEN MEDICAL INFORMATION
Call us at 1-800-526-7736
(1-800-JANSSEN)
Monday–Friday, 9am-8pm ET
Email Us
